Glecaprevir

Glecaprevir is a pan-genotypic HCV NS3/4A protease inhibitor used in combination with pibrentasvir for the treatment of chronic hepatitis C virus infection across all major genotypes. Mediocon Inc supplies pharmaceutical-grade Glecaprevir API.

Key Features

• Pan-genotypic HCV NS3/4A protease inhibitor
• Effective across HCV genotypes 1–6
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation

Applications

• Chronic hepatitis C (all genotypes)
• Antiviral combination therapy
• HCV treatment regimens
• Direct-acting antiviral formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings